{"latest_checked": "2026-07-30T11:11:26.946906+00:00", "coverage_count": 5079, "recent_count": 35, "transaction_limit": 160, "filters": {"q": "", "ticker": "DYN", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 35, "acquisition_count": 1, "disposal_count": 34, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 41494049.0982, "disposal_value_label": "$41.5M", "net_value": -41494049.0982, "net_value_label": "$-41.5M", "flow_tone": "negative", "largest_value_label": "$5.8M", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 35, "value": "41494049.0982", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$41.5M"}], "days": [{"transaction_date": "2026-06-16", "acquisitions": 0, "disposals": 3, "total": 3, "bar_width": 42.9}, {"transaction_date": "2026-06-17", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 14.3}, {"transaction_date": "2026-06-18", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 14.3}, {"transaction_date": "2026-06-22", "acquisitions": 1, "disposals": 1, "total": 2, "bar_width": 28.6}, {"transaction_date": "2026-06-23", "acquisitions": 0, "disposals": 5, "total": 5, "bar_width": 71.4}, {"transaction_date": "2026-06-24", "acquisitions": 0, "disposals": 3, "total": 3, "bar_width": 42.9}, {"transaction_date": "2026-06-25", "acquisitions": 0, "disposals": 4, "total": 4, "bar_width": 57.1}, {"transaction_date": "2026-06-26", "acquisitions": 0, "disposals": 3, "total": 3, "bar_width": 42.9}, {"transaction_date": "2026-06-29", "acquisitions": 0, "disposals": 3, "total": 3, "bar_width": 42.9}, {"transaction_date": "2026-07-06", "acquisitions": 0, "disposals": 3, "total": 3, "bar_width": 42.9}, {"transaction_date": "2026-07-07", "acquisitions": 0, "disposals": 7, "total": 7, "bar_width": 100.0}], "side_mix": {"acquisitions": 1, "disposals": 34, "acquisition_share": 2.9, "disposal_share": 97.1}}, "company_flows": [{"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "acquisitions": 1, "disposals": 34, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 41494049.0982, "disposed_value_label": "$41.5M", "net_value": -41494049.0982, "net_value_label": "$-41.5M", "acquisition_share": 2.9, "disposal_share": 97.1, "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}], "company_overview": [{"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "filings": 35, "acquisitions": 1, "disposals": 34, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 41494049.0982, "disposed_value_label": "$41.5M", "net_value": -41494049.0982, "net_value_label": "$-41.5M", "acquisition_share": 2.9, "disposal_share": 97.1, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}], "transactions": [{"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 124379.0, "share_price": 23.17, "transaction_value": 2881861.43, "fetched_at": "2026-07-27T11:12:41.927341+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 62543.0, "share_price": 23.17, "transaction_value": 1449121.31, "fetched_at": "2026-07-27T11:12:41.932422+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 49193.0, "share_price": 23.17, "transaction_value": 1139801.81, "fetched_at": "2026-07-27T11:12:41.925476+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 29587.0, "share_price": 23.62, "transaction_value": 698844.94, "fetched_at": "2026-07-27T11:12:41.923452+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 14844.0, "share_price": 23.62, "transaction_value": 350615.28, "fetched_at": "2026-07-27T11:12:41.921342+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11665.0, "share_price": 23.62, "transaction_value": 275527.3, "fetched_at": "2026-07-27T11:12:41.929174+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5000.0, "share_price": 23.61, "transaction_value": 118050.0, "fetched_at": "2026-07-27T11:12:41.930784+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 253039.0, "share_price": 22.79, "transaction_value": 5766758.81, "fetched_at": "2026-07-27T11:12:41.935678+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 127182.0, "share_price": 22.79, "transaction_value": 2898477.78, "fetched_at": "2026-07-27T11:12:41.937304+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 100019.0, "share_price": 22.79, "transaction_value": 2279433.01, "fetched_at": "2026-07-27T11:12:41.934227+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 102969.0, "share_price": 21.14, "transaction_value": 2176764.66, "fetched_at": "2026-07-20T11:07:53.418488+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 51756.0, "share_price": 21.14, "transaction_value": 1094121.84, "fetched_at": "2026-07-20T11:07:53.416456+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 40702.0, "share_price": 21.14, "transaction_value": 860440.28, "fetched_at": "2026-07-20T11:07:53.414229+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 162954.0, "share_price": 21.28, "transaction_value": 3467661.12, "fetched_at": "2026-07-16T21:55:34.008830+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 81903.0, "share_price": 21.28, "transaction_value": 1742895.84, "fetched_at": "2026-07-16T21:55:34.011279+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 64411.0, "share_price": 21.28, "transaction_value": 1370666.08, "fetched_at": "2026-07-16T21:55:34.010056+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 12699.0, "share_price": 21.1, "transaction_value": 267948.9, "fetched_at": "2026-07-16T21:55:34.013751+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 6382.0, "share_price": 21.1, "transaction_value": 134660.2, "fetched_at": "2026-07-16T21:55:34.014991+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5019.0, "share_price": 21.1, "transaction_value": 105900.9, "fetched_at": "2026-07-16T21:55:34.016249+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "LUCERA, ERICK", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2362.0, "share_price": 20.37, "transaction_value": 48113.94, "fetched_at": "2026-07-16T21:55:34.012486+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 50530.0, "share_price": 21.02, "transaction_value": 1062140.6, "fetched_at": "2026-07-15T10:45:11.296424+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 25397.0, "share_price": 21.02, "transaction_value": 533844.94, "fetched_at": "2026-07-15T10:45:11.292519+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 19973.0, "share_price": 21.02, "transaction_value": 419832.46, "fetched_at": "2026-07-15T10:45:11.288892+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 77855.0, "share_price": 21.13, "transaction_value": 1645076.15, "fetched_at": "2026-07-13T10:33:36.193261+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "KERSTEN, DIRK", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 71629.0, "share_price": 21.0357, "transaction_value": 1506766.1553, "fetched_at": "2026-07-13T10:33:36.191869+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 39131.0, "share_price": 21.13, "transaction_value": 826838.03, "fetched_at": "2026-07-13T10:33:36.190294+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "RHODES, JASON P", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 30774.0, "share_price": 21.13, "transaction_value": 650254.62, "fetched_at": "2026-07-13T10:33:36.195998+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "KERSTEN, DIRK", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1657.0, "share_price": 21.4742, "transaction_value": 35582.7494, "fetched_at": "2026-07-13T10:33:36.194505+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KERSTEN, DIRK", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 190676.0, "share_price": 20.5703, "transaction_value": 3922262.5228, "fetched_at": "2026-07-13T10:33:36.198695+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "GREENE, BARRY E", "executive_title": "Director", "security_type": "Stock option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 57463.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:33:36.197379+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "KERSTEN, DIRK", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 46901.0, "share_price": 20.0715, "transaction_value": 941373.4215, "fetched_at": "2026-07-13T10:33:36.200132+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "KERSTEN, DIRK", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 37454.0, "share_price": 20.1398, "transaction_value": 754316.0692, "fetched_at": "2026-07-13T10:33:36.201434+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "COX, JOHN", "executive_title": "Director, CEO & President", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2683.0, "share_price": 18.33, "transaction_value": 49179.39, "fetched_at": "2026-07-13T10:33:36.205513+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "KERR, DOUGLAS", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 887.0, "share_price": 18.33, "transaction_value": 16258.71, "fetched_at": "2026-07-13T10:33:36.202823+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}, {"symbol": "DYN", "name": "Dyne Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "FRIEDL-NADERER, JOHANNA", "executive_title": "Chief Commercial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 145.0, "share_price": 18.33, "transaction_value": 2657.85, "fetched_at": "2026-07-13T10:33:36.204158+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyn/", "research_links": {"chart": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/", "report": "/terminal/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/report/", "factor": "/factors/ticker/6e8f9931-6fff-42b4-bd42-3e6f93676ad7/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}